PET brain scans find links to PTSD severity in 9/11 responders
July 2, 2021 -- PET imaging has revealed a link between unusual brain activity and the severity of post-traumatic stress disorder (PTSD) in 9/11 responders due to their experiences at the World Trade Center in New York in 2001, according to a study published June 30 in Brain, Behavior, and Immunity -- Health. Read More
Ga-68 PSMA-11 improves outcomes in prostate cancer patients
July 2, 2021 -- PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotracer should be the standard imaging modality for guiding stereotactic ablative radiotherapy in oligometastatic prostate cancer patients, according to a June 29 study in Clinical and Translational Radiation Oncology. Read More
Researchers report on PET/CT's COVID-19 pandemic performance
June 28, 2021 -- When it comes to imaging diseases like COVID-19, FDG-PET/CT may not be the first modality that springs to mind. But its performance over the past year for identifying infection and inflammation in COVID-19 patients offers strong evidence of its value. Read More
Tau PET bests amyloid PET, MRI in Alzheimer's prognostic study
June 28, 2021 -- Tau PET is superior to amyloid PET and MRI for detecting cognitive decline in Alzheimer's disease patients over time and may serve as a prognostic tool to help manage patients in the early stages of the disease, according to a study published June 28 in JAMA Neurology. Read More
Patient vest monitors dose after radionuclide therapy
June 18, 2021 -- Researchers are developing a radiation tracking vest for patients to wear at home to monitor radiation dose to organs during radionuclide therapy, according to a study presented at the 2021 annual meeting of the Society of Nuclear Medicine and Molecular Imaging. Read More
Molecular imaging saw wins, losses over past year
June 17, 2021 -- You win some, you lose some. That adage could apply to the efforts of the nuclear medicine and molecular imaging community over the past year, according to the president's address by Alan Packard, PhD, at this week's annual Society of Nuclear Medicine and Molecular Imaging meeting. Read More
Healthcare disparities persist as COVID-19 pandemic fades
June 16, 2021 -- Dr. Sampson Davis, an emergency medicine physician and New York Times bestselling author, spoke at the SNMMI 2021 virtual annual meeting about his life growing up, attending medical school, and being on the frontlines of the COVID-19 pandemic. He also called others to action in the fight against racial injustice. Read More
SNMMI's Image of the Year shows COVID-19's long-term neuro effects
June 15, 2021 -- A series of FDG-PET images of COVID-19 patients that shows how the disease causes long-term neurological changes associated with cognitive impairment was given Image of the Year honors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting. Read More
FDG-PET shows lipophilic statin users at higher risk of dementia
June 15, 2021 -- FDG-PET scans showed patients taking lipophilic statins may have more than double the risk of converting to dementia over eight years of follow-up compared with those not taking statins, according to a presentation on June 14 at the Society of Nuclear Medicine and Molecular Imaging meeting. Read More
Animal study suggests Ga-68 PET FAPI can detect lung fibrosis
June 14, 2021 -- PET imaging with a gallium-68 (Ga-68)-labeled fibroblast activation protein inhibitor (FAPI) shows promise as an effective way to identify and monitor pulmonary fibrosis, according to animal study findings presented at the Society of Nuclear Medicine and Molecular Imaging meeting. Read More